• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
SG-DJ10 Capsule and Tablet Sample Checkweigher
NADP+
NMN
Ceritinib (LDK378) CAS:1032900-25-6
SG-JN10 0.1mg Tablet Capsule Check Weigher
β-Nicotinamide Adenine Dinucleotide (NAD+)

Lupin donates oxygen generation plants in Maharashtra, MP and Gujarat

expresspharmaJune 15, 2021

Tag: lupin , oxygen , Maharashtra

Lupin, through its CSR arm, the Lupin Foundation, is donating five oxygen generation plants to assist the states of Maharashtra, Madhya Pradesh and Gujarat.

These five oxygen plants have a total capacity of 3840 cubic meters of oxygen per day.

The respective State governments will oversee the distribution of the oxygen produced at these plants to Government hospitals and COVID care centres.

The company informed that it is in discussions with other states to assist them in their fight against the pandemic through similar initiatives.

Previous:CSIR-CDRI, Lucknow sign license deal with Marc Labs to develop drug for treating heart attack, stroke

Next:Biophore applies for DCGI approval for emergency use of Aviptadil to treat COVID-19

Related News

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Lupin donates oxygen generation plants in Maharashtra, MP and Gujarat | Pharmasources.com

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its Supervisory Board.

You may like
More>>

(3 r, 4 s) - 4 - [4 - (benzyl oxygen radicals) phenyl] - 1 - (4 - fluorinated phenyl) - 3 - [3 - (4

(3 r, 4 s) - 4 - [4 - (benzyl oxygen radicals) phenyl] - 1 - (4 - fluorinated phenyl) - 3 - [3 - (4

GNL-IN90 Process Trace Oxygen Analyzer

GNL-IN90 Process Trace Oxygen Analyzer
Oxygen-fluorine acid

Oxygen-fluorine acid
(2 'r) - 2 '- deoxygen-2' -fluoro1 '- methylurein

(2 'r) - 2 '- deoxygen-2' -fluoro1 '- methylurein
Pressure swing adsorption oxygen generator

Pressure swing adsorption oxygen generator
CI-PC93 Portable trace oxygen analyzer

CI-PC93 Portable trace oxygen analyzer
(6 s) - 5 - tert-butyl carbonyl oxygen - 6 - (5-7 - bromide (9, 9 - two fluorine - h - fluorene 9-2

(6 s) - 5 - tert-butyl carbonyl oxygen - 6 - (5-7 - bromide (9, 9 - two fluorine - h - fluorene 9-2

Dioxygenase(DO)

Dioxygenase(DO)
CI-PC13Portable trace oxygen analyzer

CI-PC13Portable trace oxygen analyzer
5, 6 - dihydro-3 - (4 - morpholine) - 1 - [4 - (2 - oxygen-1-piperidine) phenyl] -2 (0H) - pyridinon

5, 6 - dihydro-3 - (4 - morpholine) - 1 - [4 - (2 - oxygen-1-piperidine) phenyl] -2 (0H) - pyridinon

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service